Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2263–2275. doi: 10.1172/JCI119764

Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.

R Kalluri 1, T M Danoff 1, H Okada 1, E G Neilson 1
PMCID: PMC508422  PMID: 9410904

Abstract

We developed a new mouse model of human anti-glomerular basement membrane (GBM) disease to better characterize the genetic determinants of cell-mediated injury. While all major histocompatibility complex (MHC) haplotypes (H-2a, k, s, b, and d) immunized with alpha3 NC1 domains of type IV collagen produce anti-alpha3(IV) NC1 antibodies that cross-react with human Goodpasture [anti-GBM/anti-alpha3(IV) NC1] autoantibodies, only a few strains developed nephritis and lung hemorrhage associated with Goodpasture syndrome. Crescentic glomerulonephritis and lung hemorrhage were MHC-restricted in haplotypes H-2s, b, and d (A beta/A alpha region in H-2s) and associated with the emergence of an IL-12/Th1-like T cell phenotype. Lymphocytes or anti-alpha3(IV) NC1 antibodies from nephritogenic strains transfer disease to syngeneic recipients. However, passive transfer of isogenic alpha3(IV) NC1 antibodies into -/- T cell receptor-deficient mice failed to produce nephritis. Finally, nephritis and its associated IL-12/Th1-like T cell response attenuate in disease-susceptible mice tolerized orally to alpha3(IV) collagen before immunization. Our findings suggest collectively, as a hypothesis, that anti-GBM antibodies in mice only facilitate disease in MHC haplotypes capable of generating nephritogenic lymphocytes with special T cell repertoires.

Full Text

The Full Text of this article is available as a PDF (780.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akselband Y., Hoffer T. L., Nelson P. A., Gonnella P. A., Weiner H. L. Local and systemic immune responses in SJL/J mice during prolonged oral myelin basic protein administration. Ann N Y Acad Sci. 1996 Feb 13;778:358–361. doi: 10.1111/j.1749-6632.1996.tb21143.x. [DOI] [PubMed] [Google Scholar]
  2. Avasthi P. S., Avasthi P., Tokuda S., Anderson R. E., Williams R. C., Jr Experimental glomerulonephritis in the mouse. I. The model. Clin Exp Immunol. 1971 Nov;9(5):667–676. [PMC free article] [PubMed] [Google Scholar]
  3. Bolton W. K., Benton F. R., Sturgill B. C. Autoimmune glomerulotubular nephropathy in mice. Clin Exp Immunol. 1978 Sep;33(3):463–473. [PMC free article] [PubMed] [Google Scholar]
  4. Bolton W. K., Tucker F. L., Sturgill B. C. New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest. 1984 May;73(5):1263–1276. doi: 10.1172/JCI111328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen Y. H., Weiner H. L. Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann N Y Acad Sci. 1996 Feb 13;778:111–121. doi: 10.1111/j.1749-6632.1996.tb21120.x. [DOI] [PubMed] [Google Scholar]
  6. Chen Y., Inobe J., Weiner H. L. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol. 1995 Jul 15;155(2):910–916. [PubMed] [Google Scholar]
  7. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26;265(5176):1237–1240. doi: 10.1126/science.7520605. [DOI] [PubMed] [Google Scholar]
  8. Constant S. L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol. 1997;15:297–322. doi: 10.1146/annurev.immunol.15.1.297. [DOI] [PubMed] [Google Scholar]
  9. Couser W. G., Darby C., Salant D. J., Adler S., Stilmant M. M., Lowenstein L. M. Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am J Physiol. 1985 Aug;249(2 Pt 2):F241–F250. doi: 10.1152/ajprenal.1985.249.2.F241. [DOI] [PubMed] [Google Scholar]
  10. D'Apice A. J., Kincaid-Smith P., Becker G. H., Loughhead M. G., Freeman J. W., Sands J. M. Goodpasture's syndrome in identical twins. Ann Intern Med. 1978 Jan;88(1):61–62. doi: 10.7326/0003-4819-88-1-61. [DOI] [PubMed] [Google Scholar]
  11. Derry C. J., Ross C. N., Lombardi G., Mason P. D., Rees A. J., Lechler R. I., Pusey C. D. Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin Exp Immunol. 1995 May;100(2):262–268. doi: 10.1111/j.1365-2249.1995.tb03663.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr, Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. doi: 10.1146/annurev.iy.08.040190.001511. [DOI] [PubMed] [Google Scholar]
  13. Germain R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 Jan 28;76(2):287–299. doi: 10.1016/0092-8674(94)90336-0. [DOI] [PubMed] [Google Scholar]
  14. Gossain V. V., Gerstein A. R., Janes A. W. Goodpasture's syndrome: a familial occurrence. Am Rev Respir Dis. 1972 Apr;105(4):621–624. doi: 10.1164/arrd.1972.105.4.621. [DOI] [PubMed] [Google Scholar]
  15. Gunwar S., Ballester F., Kalluri R., Timoneda J., Chonko A. M., Edwards S. J., Noelken M. E., Hudson B. G. Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem. 1991 Aug 15;266(23):15318–15324. [PubMed] [Google Scholar]
  16. Gunwar S., Saus J., Noelken M. E., Hudson B. G. Glomerular basement membrane. Identification of a fourth chain, alpha 4, of type IV collagen. J Biol Chem. 1990 Apr 5;265(10):5466–5469. [PubMed] [Google Scholar]
  17. Güler M. L., Gorham J. D., Hsieh C. S., Mackey A. J., Steen R. G., Dietrich W. F., Murphy K. M. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science. 1996 Feb 16;271(5251):984–987. doi: 10.1126/science.271.5251.984. [DOI] [PubMed] [Google Scholar]
  18. Hill P. A., Lan H. Y., Nikolic-Paterson D. J., Atkins R. C. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. Kidney Int. 1994 Mar;45(3):700–708. doi: 10.1038/ki.1994.94. [DOI] [PubMed] [Google Scholar]
  19. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993 Apr 23;260(5107):547–549. doi: 10.1126/science.8097338. [DOI] [PubMed] [Google Scholar]
  20. Hudson B. G., Reeders S. T., Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem. 1993 Dec 15;268(35):26033–26036. [PubMed] [Google Scholar]
  21. Huey B., McCormick K., Capper J., Ratliff C., Colombe B. W., Garovoy M. R., Wilson C. B. Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization. Kidney Int. 1993 Aug;44(2):307–312. doi: 10.1038/ki.1993.245. [DOI] [PubMed] [Google Scholar]
  22. Janeway C. A., Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994 Jan 28;76(2):275–285. doi: 10.1016/0092-8674(94)90335-2. [DOI] [PubMed] [Google Scholar]
  23. Jones P. P., Murphy D. B., McDevitt H. O. Variable synthesis and expression of E alpha and Ae (E beta) Ia polypeptide chains in mice of different H-2 haplotypes. Immunogenetics. 1981;12(3-4):321–337. doi: 10.1007/BF01561674. [DOI] [PubMed] [Google Scholar]
  24. Kahsai T. Z., Enders G. C., Gunwar S., Brunmark C., Wieslander J., Kalluri R., Zhou J., Noelken M. E., Hudson B. G. Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of alpha3(IV) and alpha5(IV) chains. J Biol Chem. 1997 Jul 4;272(27):17023–17032. doi: 10.1074/jbc.272.27.17023. [DOI] [PubMed] [Google Scholar]
  25. Kalluri R., Gattone V. H., 2nd, Noelken M. E., Hudson B. G. The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6201–6205. doi: 10.1073/pnas.91.13.6201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kalluri R., Gunwar S., Reeders S. T., Morrison K. C., Mariyama M., Ebner K. E., Noelken M. E., Hudson B. G. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen. J Biol Chem. 1991 Dec 15;266(35):24018–24024. [PubMed] [Google Scholar]
  27. Kalluri R., Melendez E., Rumpf K. W., Sattler K., Müller G. A., Strutz F., Neilson E. G. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Proc Assoc Am Physicians. 1996 Mar;108(2):134–139. [PubMed] [Google Scholar]
  28. Kalluri R., Petrides S., Wilson C. B., Tomaszewski J. E., Palevsky H. I., Grippi M. A., Madaio M. P., Neilson E. G. Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med. 1996 Apr 1;124(7):651–653. doi: 10.7326/0003-4819-124-7-199604010-00005. [DOI] [PubMed] [Google Scholar]
  29. Kalluri R., Shield C. F., Todd P., Hudson B. G., Neilson E. G. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest. 1997 May 15;99(10):2470–2478. doi: 10.1172/JCI119431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kalluri R., Sun M. J., Hudson B. G., Neilson E. G. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen. J Biol Chem. 1996 Apr 12;271(15):9062–9068. doi: 10.1074/jbc.271.15.9062. [DOI] [PubMed] [Google Scholar]
  31. Kalluri R., Wilson C. B., Weber M., Gunwar S., Chonko A. M., Neilson E. G., Hudson B. G. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol. 1995 Oct;6(4):1178–1185. doi: 10.1681/ASN.V641178. [DOI] [PubMed] [Google Scholar]
  32. Kalluri R., van den Heuvel L. P., Smeets H. J., Schroder C. H., Lemmink H. H., Boutaud A., Neilson E. G., Hudson B. G. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int. 1995 Apr;47(4):1199–1204. doi: 10.1038/ki.1995.170. [DOI] [PubMed] [Google Scholar]
  33. Kelly C. J., Korngold R., Mann R., Clayman M., Haverty T., Neilson E. G. Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. J Immunol. 1986 Jan;136(2):526–531. [PubMed] [Google Scholar]
  34. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today. 1995 Aug;16(8):374–379. doi: 10.1016/0167-5699(95)80004-2. [DOI] [PubMed] [Google Scholar]
  35. Lerner R. A., Dixon F. J. Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med. 1966 Sep 1;124(3):431–442. doi: 10.1084/jem.124.3.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Madaio M. P., Salant D. J., Adler S., Darby C., Couser W. G. Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane. Kidney Int. 1984 Oct;26(4):397–403. doi: 10.1038/ki.1984.188. [DOI] [PubMed] [Google Scholar]
  37. Merkel F., Kalluri R., Marx M., Enders U., Stevanovic S., Giegerich G., Neilson E. G., Rammensee H. G., Hudson B. G., Weber M. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int. 1996 Apr;49(4):1127–1133. doi: 10.1038/ki.1996.163. [DOI] [PubMed] [Google Scholar]
  38. Mombaerts P., Mizoguchi E., Grusby M. J., Glimcher L. H., Bhan A. K., Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993 Oct 22;75(2):274–282. doi: 10.1016/0092-8674(93)80069-q. [DOI] [PubMed] [Google Scholar]
  39. Morrison K. E., Mariyama M., Yang-Feng T. L., Reeders S. T. Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. Am J Hum Genet. 1991 Sep;49(3):545–554. [PMC free article] [PubMed] [Google Scholar]
  40. Murray J. S., Madri J., Tite J., Carding S. R., Bottomly K. MHC control of CD4+ T cell subset activation. J Exp Med. 1989 Dec 1;170(6):2135–2140. doi: 10.1084/jem.170.6.2135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Neilson E. G., Kalluri R., Sun M. J., Gunwar S., Danoff T., Mariyama M., Myers J. C., Reeders S. T., Hudson B. G. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem. 1993 Apr 25;268(12):8402–8405. [PubMed] [Google Scholar]
  42. Neilson E. G., Phillips S. M. Murine interstitial nephritis. I. Analysis of disease susceptibility and its relationship of pleiomorphic gene products defining both immune-response genes and a restrictive requirement for cytotoxic T cells at H-2K. J Exp Med. 1982 Apr 1;155(4):1075–1085. doi: 10.1084/jem.155.4.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nishikawa K., Guo Y. J., Miyasaka M., Tamatani T., Collins A. B., Sy M. S., McCluskey R. T., Andres G. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med. 1993 Mar 1;177(3):667–677. doi: 10.1084/jem.177.3.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nishikawa K., Linsley P. S., Collins A. B., Stamenkovic I., McCluskey R. T., Andres G. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol. 1994 Jun;24(6):1249–1254. doi: 10.1002/eji.1830240602. [DOI] [PubMed] [Google Scholar]
  45. Noben-Trauth N., Kropf P., Müller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science. 1996 Feb 16;271(5251):987–990. doi: 10.1126/science.271.5251.987. [DOI] [PubMed] [Google Scholar]
  46. Perez V. L., Lederer J. A., Lichtman A. H., Abbas A. K. Stability of Th1 and Th2 populations. Int Immunol. 1995 May;7(5):869–875. doi: 10.1093/intimm/7.5.869. [DOI] [PubMed] [Google Scholar]
  47. Pfeiffer C., Murray J., Madri J., Bottomly K. Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV. Immunol Rev. 1991 Oct;123:65–84. doi: 10.1111/j.1600-065x.1991.tb00606.x. [DOI] [PubMed] [Google Scholar]
  48. Pfeiffer C., Stein J., Southwood S., Ketelaar H., Sette A., Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 1995 Apr 1;181(4):1569–1574. doi: 10.1084/jem.181.4.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rees A. J., Peters D. K., Amos N., Welsh K. I., Batchelor J. R. The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int. 1984 Oct;26(4):445–450. doi: 10.1038/ki.1984.194. [DOI] [PubMed] [Google Scholar]
  50. Riblet R., Brodeur P. H. The Igh-V gene repertoire of the mouse. Mt Sinai J Med. 1986 Mar;53(3):170–174. [PubMed] [Google Scholar]
  51. Riblet R., Tutter A., Brodeur P. Polymorphism and evolution of Igh-V gene families. Curr Top Microbiol Immunol. 1986;127:168–172. [PubMed] [Google Scholar]
  52. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol. 1995 May;15(3):121–129. doi: 10.1007/BF01543103. [DOI] [PubMed] [Google Scholar]
  53. STEBLAY R. W. Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant. J Exp Med. 1962 Aug 1;116:253–272. doi: 10.1084/jem.116.2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Salant D. J., Cybulsky A. V. Experimental glomerulonephritis. Methods Enzymol. 1988;162:421–461. doi: 10.1016/0076-6879(88)62096-9. [DOI] [PubMed] [Google Scholar]
  55. Sayegh M. H., Khoury S. J., Hancock W. W., Weiner H. L., Carpenter C. B. Mechanisms of oral tolerance by MHC peptides. Ann N Y Acad Sci. 1996 Feb 13;778:338–345. doi: 10.1111/j.1749-6632.1996.tb21141.x. [DOI] [PubMed] [Google Scholar]
  56. Schwartz R. H., Merryman C. F., Maurer P. H. Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): evidence for effects of polymer handling and gene dosage. J Immunol. 1979 Jul;123(1):272–278. [PubMed] [Google Scholar]
  57. Seder R. A., Gazzinelli R., Sher A., Paul W. E. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10188–10192. doi: 10.1073/pnas.90.21.10188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Seder R. A., Paul W. E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol. 1994;12:635–673. doi: 10.1146/annurev.iy.12.040194.003223. [DOI] [PubMed] [Google Scholar]
  59. Sosroseno W. A review of the mechanisms of oral tolerance and immunotherapy. J R Soc Med. 1995 Jan;88(1):14–17. [PMC free article] [PubMed] [Google Scholar]
  60. Strutz F., Okada H., Lo C. W., Danoff T., Carone R. L., Tomaszewski J. E., Neilson E. G. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995 Jul;130(2):393–405. doi: 10.1083/jcb.130.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Weiner H. L., Friedman A., Miller A., Khoury S. J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]
  62. Weiner H. L. Oral tolerance. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10762–10765. doi: 10.1073/pnas.91.23.10762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wick G., Von der Mark H., Dietrich H., Timpl R. Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease. Lab Invest. 1986 Sep;55(3):308–317. [PubMed] [Google Scholar]
  64. Zakheim B., McCafferty E., Phillips S. M., Clayman M., Neilson E. G. Murine interstitial nephritis. II. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J Immunol. 1984 Jul;133(1):234–239. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES